APSD of Aqueous Droplet Inhalers (ADIs)
For ADIs as for nebulisers, the evaporation of droplets exacerbated by the thermal mass of the impactor can be a problem. Loss of solvent reduces droplet size, producing artificially low APSD measurements, compromising the integrity of the resulting data. Cooling the impactor to approximately 5°C is the recommended method for overcoming this problem. Classified as active devices, the recommended flow rate for ADI testing is 28.3 L/min for the ACI or 30 L/min for the NGI.
Mouthpiece Adapter
View ProductNGI Induction Port
View BrochureNext Generation Impactor NGI
View BrochureBAC 100i Breath Actuation Controller
View ProductLCP6 Low Capacity Vacuum Pump
View ProductFlow Rate Sensor FRS
View ProductNGI Cooler
View ProductInhalytix® – APSD Data Analysis Software
View ProductTemperature and Relative Humidity Sensor
View BrochureFootswitch
View BrochureNGI Cup Rack
View BrochureNGI Carrying/Washing Rack
View BrochureInternal/External Filter Holder
View BrochureDFM 2000 Flow Meter
View ProductHCP6 High Capacity Vacuum Pump
View ProductDDU of Aqueous Droplet Inhalers (ADIs)
View SystemMouthpiece Adapter
View ProductNGI Induction Port
View BrochureNext Generation Impactor NGI
View BrochureBAC 100i Breath Actuation Controller
View ProductLCP6 Low Capacity Vacuum Pump
View ProductFlow Rate Sensor FRS
View ProductNGI Cooler
View ProductInhalytix® – APSD Data Analysis Software
View ProductTemperature and Relative Humidity Sensor
View BrochureFootswitch
View BrochureNGI Cup Rack
View BrochureNGI Carrying/Washing Rack
View BrochureInternal/External Filter Holder
View BrochureDFM 2000 Flow Meter
View ProductHCP6 High Capacity Vacuum Pump
View ProductDDU of Aqueous Droplet Inhalers (ADIs)
View SystemRelated Applications
We also offer a range of equipment for additional DPI testing application support:
Related Applications
Two factors have been identified as being critical to improving the clinical relevance of DDU testing and APSD measurement: realistic breathing profiles and realistic throat and nasal models.
View MoreSemi-Automation Tools
Semi-Automation Tools
Copley supplies a broad range of labour-saving devices and semi-automated systems for Aerodynamic Particle Size Distribution applications.
View Product RangeSample Preparation Unit SPU 200i
Copley supplies a broad range of labour-saving dev…
View Product RangeSemi-Automation Tools
Copley supplies a broad range of labour-saving devices and semi-automated systems for Aerodynamic Particle Size Distribution applications.
View Product RangeSemi-Automation Tools
Copley supplies a broad range of labour-saving devices and semi-automated systems for Aerodynamic Particle Size Distribution applications.
View Product RangeSemi-Automation Tools
Copley supplies a broad range of labour-saving devices and semi-automated systems for Aerodynamic Particle Size Distribution applications.
View Product RangeHow Does a Cascade Impactor Work?
Play VideoRelated Services

Training
We offer a range of training courses, presentations and seminars covering a wide range of topics.
Find Out More
Servicing
A comprehensive range of both in-house and on-site product servicing options are available
Find Out More
Support
Our team of experienced technicians and engineers are on hand to help and advise
Find Out MoreRelated News & Resources

Copley introduces the new Flow Rate Sensor, a dedicated device for inhaler testing systems.
27 June 2023; Nottingham, UK: The new Flow Rate Sensor FRS is the latest addition to Copley Scientific’s orally inhaled and nasal drug product…
Find Out More
Copley’s appointment of new Applications Specialist, Clair Brooks, highlights commitment to exemplary customer support.
23 May 2023; Nottingham, UK: Copley Scientific, a major provider of pharmaceutical testing systems with world-renowned expertise in the field of orally inhaled and…
Find Out More
Introducing the Copley Impactor Genie™ IG 200i, a two-in-one solution for quicker, more efficient inhaled product testing
25th April 2023; Nottingham, UK: The new Impactor Genie™ IG 200i from Copley Scientific is a cost- and space-efficient semi-automation tool for regulatory and…
Find Out More
Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing
14 September 2022; Nottingham, UK: EnviroMate™ is a benchtop environmental control chamber from Copley, the world’s leading manufacturer and supplier of inhaler testing equipment,…
Find Out More
Copley launches a new semi-automation tool for inhaled product testing
28 April 2022; Nottingham, UK: Copley Scientific, the global leader in inhaled product testing equipment, has launched the new Gentle Rocker 100i, a simple,…
Find Out More
Copley Scientific joins the Industries Forum of the Taskforce for Lung Health
23 June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over…
Find Out More
Introducing Inhalytix™: a new solution for analysing and managing inhaler test data from Copley
18 March 2021; Nottingham, UK: Inhalytix™ is a completely new software solution from Copley, the global leader in inhaler testing equipment, that brings a…
Find Out More
Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio
01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company’s 75th anniversary with a significant upgrade…
Find Out More
New e-Training service from Copley for pharmaceutical testing
14 January 2021; Nottingham, UK: Copley Scientific is now delivering e-Training, offering customers across the globe remote access to expert tuition on in vitro…
Find Out More
Copley launches a new webinar series on inhaler testing
20 April 2020; Nottingham, UK: Copley Scientific will shortly begin the company’s inaugural series of technical webinars, offering valuable, easy to understand overviews on…
Find Out More
Advancing the science of OINDPs: Copley Scientific joins IPAC-RS
28 February 2018; Nottingham, UK: Copley Scientific, a global leader in the design and manufacture of inhaler testing equipment, is pleased to announce that…
Find Out More
Confused about cascade impaction? Watch the new animations from Copley Scientific to improve your understanding of inhaled drug product testing.
22nd August 2016; Nottingham, UK: Copley Scientific, the world’s leading manufacturer and supplier of inhaler test equipment, has released two new educational animations that…
Find Out More
New maintenance tools from Copley Scientific help optimise inhaler testing
30 June 2009; Nottingham, UK: New pinning kits from Copley Scientific provide users of cascade impactors with a valuable tool for maintaining the longterm…
Find Out More
New, state-of-the-art vision system central to Copley Scientific’s cascade impactor validation service
24 July 2007; Nottingham, UK: The accuracy of cascade impactors used in the pharmaceutical industry for characterising inhaled products depends heavily on the size…
Find Out More
White paper: October 2023
Understanding the links between drug delivery route and in vitro test methods In this white paper, we review the drug product characteristics that define…
Find Out More
Q&A: OINDPnews 2022
Reducing Inhaler Testing Variability Through Test Environment Control In this Q&A with OINDPnews, our CEO Mark Copley answers questions about the importance of the…
Find Out More
DDD 2021 Respiratory eBook Profile
Semi-Automating Inhaler Testing – A Good Idea, but Where to Start? Cascade impaction is a vital technique in the development and manufacture of orally…
Find Out More
PMPS Q&A (Samedan): April 2021
Putting Inhalers to the Test Anna Sipitanou has worked for Copley Scientific for four years, expanding her drug discovery and pharma science background. She…
Find Out More
Microbioz India: February 2021
A short Q&A with our CEO, Mark Copley, on inhaled product testing
Find Out More
ONdrugDelivery Article: November 2020
Semi-Automation in Inhaler Testing – Exploring the Potential and Practicalities In this article, João Pereira, Team Leader R&D Analytical Development, and Raquel Borda D’Água,…
Find Out More
Inhalation Article: December 2019
Optimizing the role of automation in variability reduction strategies for delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD) testing of inhaled drug…
Find Out More
Inhalation Article: April 2019
The regulatory landscape for OINDPs – the biggest shake-up in a generation?
Find Out More
ONdrugDelivery Article: December 2018
Variability in cascade impaction: sources, impact and strategies for reduction In this article, Mark Copley, Chief Executive Officer, Copley Scientific, considers cascade impaction as…
Find Out More
Drug Development & Delivery Article: April 2018
Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products
Find Out More
PMPS Article (Samedan): February 2018
Demonstrating Bioequivalence of Orally Inhaled Products Safe and cost-effective treatments for respiratory diseases are facing a growing demand. The demonstration of bioequivalence within locally…
Find Out More
White Paper: February 2018
Optimising the application of in vitro test methods for the demonstration of BE in OIPs
Find Out MoreHave a question? Our friendly and experienced team are here to help.